VEGF with AMD3100 endogenously mobilizes mesenchymal stem cells and improves fracture healing

被引:19
作者
Meeson, Richard [1 ,2 ]
Sanghani-Keri, Anita [1 ]
Coathup, Melanie [1 ,3 ]
Blunn, Gordon [1 ,4 ]
机构
[1] Univ Coll London, Div Surg, Stanmore, Middx, England
[2] Royal Vet Coll, Hatfield, Herts, England
[3] Univ Cent Florida, Orlando, FL 32816 USA
[4] Univ Portsmouth, Portsmouth, Hants, England
基金
英国医学研究理事会;
关键词
mobilization; mesenchymal stem cells; AMD3100; VEGF; fracture healing; BONE-MARROW; PERIPHERAL-BLOOD; PROGENITOR CELLS; IN-VIVO; BIOLOGICAL CHARACTERISTICS; PRECURSOR CELLS; ANGIOGENESIS; MIGRATION; REPAIR; ANTAGONIST;
D O I
10.1002/jor.24164
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
A significant number of fractures develop non-union. Mesenchymal stem cell (MSC) therapy may be beneficial, however, this requires cell acquisition, culture and delivery. Endogenous mobilization of stem cells offers a non-invasive alternative. The hypothesis was administration of VEGF and the CXCR4 antagonist AMD3100 would increase the circulating pool of available MSCs and improve fracture healing. Ex-breeder female wistar rats received VEGF followed by AMD3100, or sham PBS. Blood prepared for culture and colonies were counted. P3 cells were analyzed by flow cytometry, bi-differentiation. The effect of mobilization on fracture healing was evaluated with 1.5 mm femoral osteotomy stabilized with an external fixator in 12-14 week old female Wistars. The mobilized group had significantly greater number of cfus/ml compared to controls, p = 0.029. The isolated cells expressed 1.8% CD34, 35% CD45, 61% CD29, 78% CD90, and differentiated into osteoblasts but not into adipocytes. The fracture gap in animals treated with VEGF and AMD3100 showed increased bone volume; 5.22 +/- 1.7 mu m(3) and trabecular thickness 0.05 +/- 0.01 mu m compared with control animals (4.3 +/- 3.1 mu m(3), 0.04 +/- 0.01 mu m, respectively). Radiographic scores quantifying fracture healing (RUST) showed that the animals in the mobilization group had a higher healing score compared to controls (9.6 vs. 7.7). Histologically, mobilization resulted in significantly lower group variability in bone formation (p = 0.032) and greater amounts of bone and less fibrous tissue than the control group. Clinical significance: This pre-clinical study demonstrates a beneficial effect of endogenous MSC mobilization on fracture healing, which may have translation potential to prevent or treat clinical fractures at risk of delayed or non-union fractures. (c) 2018 The Authors. Journal of Orthopaedic Research (R) Published by Wiley Periodicals, Inc. on behalf of Orthopaedic Research Society. J Orthop Res 37:1294-1302, 2019.
引用
收藏
页码:1294 / 1302
页数:9
相关论文
共 50 条
  • [31] Short-wave enhances mesenchymal stem cell recruitment in fracture healing by increasing HIF-1 in callus
    Ye, Dongmei
    Chen, Chen
    Wang, Qiwen
    Zhang, Qi
    Li, Sha
    Liu, Hongwei
    STEM CELL RESEARCH & THERAPY, 2020, 11 (01)
  • [32] The CXCR4 Antagonist, AMD3100, Reverses Mesenchymal Stem Cell-Mediated Drug Resistance in Relapsed/Refractory Acute Lymphoblastic Leukemia
    Wang, Shan
    Wang, Xiaojiao
    Liu, Sha
    Zhang, Shengnan
    Wei, Xudong
    Song, Yongping
    Yin, Qingsong
    ONCOTARGETS AND THERAPY, 2020, 13 : 6583 - 6591
  • [33] Mesenchymal stem cells for tendon healing: what is on the horizon?
    Veronesi, Francesca
    Salamanna, Francesca
    Tschon, Matilde
    Maglio, Melania
    Aldini, Nicolo Nicoli
    Fini, Milena
    JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE, 2017, 11 (11) : 3202 - 3219
  • [34] Mesenchymal stem cells: The roles and functions in cutaneous wound healing and tumor growth
    Motegi, Sei-ichiro
    Ishikawa, Osamu
    JOURNAL OF DERMATOLOGICAL SCIENCE, 2017, 86 (02) : 83 - 89
  • [35] Neurogenic Potential of Engineered Mesenchymal Stem Cells Overexpressing VEGF
    Man, Alan J.
    Kujawski, Gregory
    Burns, Travis S.
    Miller, Elaine N.
    Fierro, Fernando A.
    Leach, J. Kent
    Bannerman, Peter
    CELLULAR AND MOLECULAR BIOENGINEERING, 2016, 9 (01) : 96 - 106
  • [36] Diabetes reduces mesenchymal stem cells in fracture healing through a TNFα-mediated mechanism
    Ko, Kang I.
    Coimbra, Leila S.
    Tian, Chen
    Alblowi, Jazia
    Kayal, Rayyan A.
    Einhorn, Thomas A.
    Gerstenfeld, Louis C.
    Pignolo, Robert J.
    Graves, Dana T.
    DIABETOLOGIA, 2015, 58 (03) : 633 - 642
  • [37] Human skin-derived mesenchymal stem cells as a source of VEGF and nitric oxide
    Salvolini, Eleonora
    Lucarini, Guendalina
    Zizzi, Antonio
    Orciani, Monia
    Di Benedetto, Giovanni
    Di Primio, Roberto
    ARCHIVES OF DERMATOLOGICAL RESEARCH, 2010, 302 (05) : 367 - 374
  • [38] Mesenchymal Stem Cells and Insulin-Like Growth Factor-I Gene-Enhanced Mesenchymal Stem Cells Improve Structural Aspects of Healing in Equine Flexor Digitorum Superficialis Tendons
    Schnabel, Lauren V.
    Lynch, Maureen E.
    van der Meulen, Marjolein C. H.
    Yeager, Amy E.
    Kornatowski, Matthew A.
    Nixon, Alan J.
    JOURNAL OF ORTHOPAEDIC RESEARCH, 2009, 27 (10) : 1392 - 1398
  • [39] AMD3100 and SDF-1 regulate cellular functions of endothelial progenitor cells and accelerate endothelial regeneration in a rat carotid artery injury model
    Jiang, Chunyu
    Li, Ruiting
    Ma, Xu
    Hu, Hui
    Guo, Juan
    Zhao, Jungong
    MOLECULAR MEDICINE REPORTS, 2020, 22 (04) : 3201 - 3212
  • [40] Detection of endogenously circulating mesenchymal stem cells in human cancer patients
    van der Velden, Daphne L.
    Houthuijzen, Julia M.
    Roodhart, Jeanine M. L.
    van Werkhoven, Erik
    Voest, Emile E.
    INTERNATIONAL JOURNAL OF CANCER, 2018, 143 (10) : 2516 - 2524